Allergan buys CNS company Naurex for $560mm
Allergan PLC acquired Naurex Inc., a closely held neurological drug developer, for $560mm in cash--$460mm at closing and $100mm by January 2016. In addition, Allergan may pay R&D and sales earn-outs.
- Drug Discovery Technologies
- Large Molecule
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash for Equity
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.